Statement Of Cash Flows [Abstract]

Ascelia Pharma - Filing #701899

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
130 031 SEK
84 834 SEK
Increase (decrease) in working capital
13 472 SEK
693,000 SEK
Adjustments for decrease (increase) in trade and other receivables
900,000 SEK
1 696 SEK
Adjustments for increase (decrease) in other liabilities
10 004 SEK
3 094 SEK
Adjustments for decrease (increase) in other current assets
2 110 SEK
4 263 SEK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) decrease (increase) in short-term deposits and investments
- SEK
76 388 SEK
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
13 271 SEK
5 285 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.